Clinical questions
- Does the standard lipid profile explain all the observed risk?
- Are there changes in lipoprotein particle number, size or subclasses?
- How can we compare progress after an intervention?
- What information would make the conversation with the patient clearer?
- How is insulin resistance reflected in the lipoprotein profile?
- Does residual risk persist even when LDL cholesterol is at target?